Anebulo Pharmaceuticals, Inc. 8-K

What Happened

• On February 12, 2026, Anebulo Pharmaceuticals, Inc. announced its financial results and provided a business update for the quarter ended December 31, 2025 via a press release. The press release is furnished as Exhibit 99.1 to the Current Report on Form 8-K.
• The company notes the information in the 8-K (including the press release) is furnished and therefore is not deemed “filed” under Section 18 of the Exchange Act and is not automatically incorporated by reference in other filings.

Key Details

• Press release date: February 12, 2026.
• Reporting period: quarter ended December 31, 2025.
• Exhibit furnished: Exhibit 99.1 (press release); Exhibit 104 (Inline XBRL cover page).
• Notice: Information is furnished, not filed, and not subject to Section 18 liabilities or automatic incorporation by reference.

Why It Matters

• This 8-K signals that Anebulo has released its latest quarterly results and a business update—key information for assessing recent earnings, revenue, cash position, and operational progress. Retail investors should read the furnished press release to see reported metrics and any management commentary.
• Because the press release is furnished (not filed), investors should also review other SEC filings for fully filed financial statements and disclosures that carry different legal status and potential liability.